Your account is not claimed yet. You can sign up with ORCID to claim your account.

Dong-Yeop Shin

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Venues

Cancer medicine

Biomedicines

Leukemia & lymphoma

Journal of clinical medicine

Seoul National University Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Seoul National University Hospital Mar 1o 2016

South Korea

Assistant Professor :: Internal Medicine

Publications

You Jung Hwang, Dong-Yeop Shin, Min-Jung Kim, Hyosun Jang, Soyeon Kim, Hyunwon Yang, Won Il Jang, Sunhoo Park, Sehwan Shim, Seung Bum Lee
StemRegenin 1 Mitigates Radiation-Mediated Hematopoietic Injury by Modulating Radioresponse of Hematopoietic Stem/Progenitor Cells. Biomedicines 11 (3) (2023)
Eun Hee Jung, Ja Min Byun, Dong-Yeop Shin, Young Rok Do, Jae-Cheol Jo, Sang Min Lee, Sung Soo Yoon
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122). Cancer medicine (2023)
Dong-Yeop Shin
TP53 Mutation in Acute Myeloid Leukemia: An Old Foe Revisited. Cancers 15 (19) (2023)
You Jung Hwang, Dong-Yeop Shin, Min-Jung Kim, Hyosun Jang, Soyeon Kim, Hyunwon Yang, Won Il Jang, Sunhoo Park, Sehwan Shim, Seung Bum Lee
StemRegenin 1 Mitigates Radiation-Mediated Hematopoietic Injury by Modulating Radioresponse of Hematopoietic Stem/Progenitor Cells. Biomedicines 11 (3) (2023)
Song Lee Bak, Dong-Yeop Shin, Junseo Steve Park, Chan Ho Park, Soo Young Moon, Sung-Soo Yoon, Dong-Soon Lee
Increased Apoptotic Activity in Low-Risk Myelodysplastic Syndrome. Journal of clinical medicine 11 (15) (2022)
Jihoon G Yoon, Seoungbok Lee, Sheehyun Kim, Man Jin Kim, Yoon Hwan Chang, Jin-Kyun Park, Dong-Yeop Shin, Jangsup Moon
The First Korean Case of VEXAS Syndrome Caused by a <i>UBA1</i> Somatic Variant. Annals of laboratory medicine 43 (2) (2022)
Hyun Jin Ahn, Ja Min Byun, Inho Kim, Jeonghwan Youk, Youngil Koh, Dong-Yeop Shin, Junshik Hong, Sung Soo Yoon
Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients. Journal of Korean medical science 37 (6) (2022)
Heejoo Han, Dong-Yeop Shin, Dongchan Kim, Hyungsuk Kim, Chansup Lee, Youngil Koh, Junshik Hong, Sung-Soo Yoon
Induction of leukemic stem cell differentiation by aryl hydrocarbon receptor agonist and synergy with gilteritinib in FLT3-ITD + acute myeloid leukemia. Leukemia & lymphoma 61 (8) (2020)
Ja Min Byun, Dong-Yeop Shin, Junshik Hong, Inho Kim, Hyun Kyung Kim, Dong Soon Lee, Youngil Koh, Sung-Soo Yoon
Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high-risk multiple myeloma in Asian patients. Cancer medicine 7 (3) (2018)
Jung Hoon Shin, Youngil Koh, Seo Hyun Yoon, Joo-Youn Cho, Dae-Young Kim, Kyoo-Hyung Lee, Hyeong-Joon Kim, Jae-Sook Ahn, Yeo-Kyeoung Kim, Jinny Park, Sang-Kyun Sohn, Joon Ho Moon, Yoo Jin Lee, Seonghae Yoon, Jeong-Ok Lee, June-Won Cheong, Kyoung Ha Kim, Sung-Hyun Kim, Hoon-Gu Kim, Hawk Kim, Seung-Hyun Nam, Young Rok Do, Sang-Gon Park, Seong Kyu Park, Sung Hwa Bae, Hun Ho Song, Dong-Yeop Shin, Doyeun Oh, Min Kyoung Kim, Chul Won Jung, Seonyang Park, Inho Kim
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea. Cancer medicine 7 (5) (2018)

Dong-Yeop Shin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dong-Yeop Shin